XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

31 - 40 of 119 search results for !padrenullquery -UclCommunicationType:"announcement" UclOrgUnit:"cancer institute"

Results

  1. Genome sequencing reveals complexity of undifferentiated sarcoma |…

    https://www.ucl.ac.uk/cancer/news/2019/mar/genome-sequencing-reveals-complexity-undifferentiated-sarcoma

    18 Mar 2019: A team of researchers has unpicked the complexity of an unusual group of rare tumours, a subset of which might be candidates for immune checkpoint inhibitor therapies.

    A team of researchers has unpicked the complexity of an unusual group of rare tumours, a subset of which might be candidates for immune checkpoint inhibitor therapies.

  2. Masterswitch discovered in body’s immune system | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2019/feb/masterswitch-discovered-bodys-immune-system

    12 Feb 2019: A critical pathway within the body’s immune system has been discovered which could potentially lead to new treatments for some of the most devastating human diseases, finds a new study co-authored by Prof Richard Jenner (UCL) and Prof Graham Lord

    A critical pathway within the body’s immune system has been discovered which could potentially lead to new treatments for some of the most devastating human diseases, finds a new study co-authored by Prof Richard Jenner (UCL) and Prof Graham Lord

  3. Search to uncover genetic secrets of sarcoma | UCL Cancer Institute - …

    https://www.ucl.ac.uk/cancer/news/2019/feb/search-uncover-genetic-secrets-sarcoma

    12 Feb 2019: A major new piece of research, led by Professor Adrienne Flanagan, will bring together 35 scientific experts from across the UK to investigate approximately 1,000 genetic sarcoma samples collected from the Government’s 100,000 Genomes Project.

    A major new piece of research, led by Professor Adrienne Flanagan, will bring together 35 scientific experts from across the UK to investigate approximately 1,000 genetic sarcoma samples collected from the Government’s 100,000 Genomes Project.

  4. UCL academics cited in global list of influential researchers | UCL…

    https://www.ucl.ac.uk/cancer/news/2018/nov/ucl-academics-cited-global-list-influential-researchers

    28 Nov 2018: A total of 41 researchers from UCL, including Professors Gerhardt Attard and Javier Herrero, have been named in Clarivate’s ‘Highly Cited Researchers 2018’ list, which recognises authors of the most influential research papers around the world.

    A total of 41 researchers from UCL, including Professors Gerhardt Attard and Javier Herrero, have been named in Clarivate’s ‘Highly Cited Researchers 2018’ list, which recognises authors of the most influential research papers around the world.

  5. Advancing personalised medicine research with open access genomic…

    https://www.ucl.ac.uk/cancer/news/2018/nov/advancing-personalised-medicine-research-open-access-genomic-data

    28 Nov 2018: Today sees the landmark publication of the Personal Genome Project UK pilot study, which demonstrates the feasibility of publicly sharing personal genomics data as part of a growing network of PGPs dedicated to enabling research into personal

    Today sees the landmark publication of the Personal Genome Project UK pilot study, which demonstrates the feasibility of publicly sharing personal genomics data as part of a growing network of PGPs dedicated to enabling research into personal

  6. Study reveals new drug target could control onset of…

    https://www.ucl.ac.uk/cancer/news/2018/nov/study-reveals-new-drug-target-could-control-onset-neurodegenerative-and-inflammatory

    14 Nov 2018: UCL researchers have discovered a new checkpoint that prevents a certain type of cell death from occurring. The findings could help scientists and doctors further understand – and potentially slow down or even halt – the progression of

    UCL researchers have discovered a new checkpoint that prevents a certain type of cell death from occurring. The findings could help scientists and doctors further understand – and potentially slow down or even halt – the progression of

  7. Urine test could help monitor bladder cancer treatment | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2018/sep/urine-test-could-help-monitor-bladder-cancer-treatment

    27 Sep 2018: Researchers at UCL Cancer Institute have shown for the first time that immune cells found within the urine mirror those found in cancerous bladder tumours.

    Researchers at UCL Cancer Institute have shown for the first time that immune cells found within the urine mirror those found in cancerous bladder tumours.

  8. Charles Swanton receives lifetime scientific achievement award | UCL…

    https://www.ucl.ac.uk/cancer/news/2018/sep/charles-swanton-receives-lifetime-scientific-achievement-award

    26 Sep 2018: Leading oncologist Professor Charles Swanton has been honoured by the International Association for the Study of Lung Cancer (IASLC) with the prestigious Paul A. Bunn, Jr. Scientific Award.

    Leading oncologist Professor Charles Swanton has been honoured by the International Association for the Study of Lung Cancer (IASLC) with the prestigious Paul A. Bunn, Jr. Scientific Award.

  9. UCL key partner in £14m cancer biotherapeutics research hub | UCL…

    https://www.ucl.ac.uk/cancer/news/2018/sep/ucl-key-partner-ps14m-cancer-biotherapeutics-research-hub

    17 Sep 2018: Researchers at UCL will play a leading role in a new world class hub for cancer biotherapeutics, which has been launched by Cancer Research UK.

    Researchers at UCL will play a leading role in a new world class hub for cancer biotherapeutics, which has been launched by Cancer Research UK.

  10. Researchers welcome NHS roll out of CAR T therapy | UCL Cancer…

    https://www.ucl.ac.uk/cancer/news/2018/sep/researchers-welcome-nhs-roll-out-car-t-therapy

    7 Sep 2018: NHS England’s announcement that children and young people with leukaemia will receive a ‘revolutionary’ treatment has been welcomed by the UCL Cancer Institute, which has helped develop the therapy.

    NHS England’s announcement that children and young people with leukaemia will receive a ‘revolutionary’ treatment has been welcomed by the UCL Cancer Institute, which has helped develop the therapy.

Pagination

Refine

Subjects

Organisational Units

Communication types

Audiences